Eternygen GmbH
c/o Bayer CoLaborator (Gebäude S141)
Müllerstr. 178
Berlin
13353
Germany
Tel: 49-30-1207-6983-0
Fax: 49-30-1207-6983-3
Website: http://www.eternygen.de/
Email: m.janezic@eternygen.com
About Eternygen GmbH
Eternygen is a Berlin based start up founded in June 2012 focusing on research and development of innovative drugs using a network of renowned scientists and contract research organizations. The main focus of Eternygen’s development and core competences of its founders are research and development of new drugs for dietary-related metabolic diseases with dramatically increasing prevalences in the last decades. Eternygen’s research addresses the sodium coupled citrate transporter NaCT which is a key regulator of lipid metabolism involved in the pathogenesis of fatty liver, diabetes and obesity.YEAR FOUNDED:
June 2012
LEADERSHIP:
Founders: Andreas Birkenfeld and Jens Jordan
CEO: Marco Janezic